Source: Globe Newswire Journey Medical Corporation, a Fortress Biotech, Inc. (FBIO) company, launched Targadox™ (doxycycline hyclate USP) 50 mg film…...
Latest News
Eli Lilly’s new psoriasis treatment Taltz launches first ads, chasing Novartis’ Cosentyx lead
Source: Playing catch-up in the next-gen psoriasis market, Eli Lilly is going all out with its first ad campaign for…...
Samsung Biologics Korean IPO to Raise as Much as $2 Billion
Source: Bloomberg Samsung Biologics Co. is seeking to raise as much as 2.25 trillion won ($2 billion) from a South…...
IPO pop! Durham pharmaceutical firm Novan stock skyrockets 70%
Source: WRAL TechWire Durham-based Novan goes public at $11 a share - and its stock shows plenty of "pop," surging…...
Allergan to Buy Vitae Pharmaceuticals for $639 Million
Source: Allergan PLC agreed to acquire clinical-stage biotechnology company Vitae Pharmaceuticals Inc. for $639 million, more than double its market…...
Horizon Pharma to buy Raptor Pharma for $800 mln
Source: Horizon Pharma Plc (HZNP.O) said it would buy Raptor Pharmaceutical Corp (RPTP.O) for nearly $800 million to bolster its…...
Celgene off-label marketing lawsuit documents unsealed
Source: Celgene ($CELG) has successfully fought off several lawsuits suggesting the success of its blockbuster multiple myeloma meds Revlimid and…...
Dermatology biotech Novan goes for $60M IPO
Source: FierceBiotech The late-stage skin condition biotech Novan is looking to batter ongoing headwinds and gun for a $60 million…...
Allergan’s newest Kybella targets? Bra-line, ankle fat
Source: Allergan ($AGN) thinks facial injectable Kybella has the potential to one day bank Botox-level sales. And the company is…...
Valeant under criminal investigation over Philidor ties: WSJ
Source: Reuters U.S. prosecutors have opened a criminal investigation into Valeant Pharmaceuticals International Inc (VRX.N) over whether it hid from…...